Patents expiring in 2029

US 7572764

Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds

State of Israel, Prime Minister's Office, Israel Insitute For Biological Research · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572449

Vaccine against Yersinia comprising one or two antibodies, one specific for Yersinia pestis F1-antigen and the other one for Yersinia pestis V-antigen

The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572442

Selected antibody compositions for binding to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572245

Application of a therapeutic substance to a tissue location using an expandable medical device

ATRIUM MEDICAL CORPORATION · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572574

Method of measuring neprilysin activity

Takeda Pharmaceutical Company Limited · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572641

Pharmaceutical compositions comprising meloxicam and methods of their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572448

Combined cancer treatment methods using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572834

Rasagiline formulations and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572788

Compositions and methods relating to novel compounds and targets thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572771

Multi-domain amphipathic helical peptides and methods of their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572789

Salts of potassium ATP channel openers and uses thereof

ESSENTIALIS, INC. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572887

Gene expressed in prostate cancer, methods and use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572918

Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

Theravance, Inc. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572893

IL-1 antagonist formulations

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572914

Kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572920

Benzimidazole derivative and use as a II receptor antagonist

Takeda Pharmaceutical Company Limited · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7574340

Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7575904

Polymer grafting by polysaccharide synthases

The Board of Regents of the University of Oklahoma · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7576050

GLP-1 exendin-4 peptide analogs and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7576175

Alpha-4 beta-1 integrin ligands for imaging and therapy

The Regents of the University of California · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7576100

Muscarinic agonists

ACADIA Pharmaceuticals Inc. · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7576130

Dihydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7575742

Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7576076

Modified pyrimidine glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7576078

Tetrahydroquinoline analogues as muscarinic agonists

ACADIA Pharmaceuticals Inc. · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7576065

Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7576053

Methods and compositions for treating degenerative bone disorders

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7575873

Reagents for diagnosing, imaging and treating atherosclerotic disease

The Regents of the University of California · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7576194

UspA2 nucleic acid of moraxella catarrhalis

The Board of Regents of the University of Texas System · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7579188

Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

The Regents of the University of California · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7579006

Method of treating immune pathologies with low dose estrogen

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIR · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7579014

Mesoporous compositions for use in drug delivery

The Board of Regents of the University of Texas System · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7579319

Methods for improving the structure and function of arterioles

The Regents of the University of California · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7579453

Variants of human taste receptor genes

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7579444

Polymer-factor IX moiety conjugates

Nektar Therapeutics AL, Corporation · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7579451

Oligonucleotides comprising a modified or non-natural nucleobase

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7578998

Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use

UNIVERSITY OF CONNECTICUT · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7579357

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7579333

Therapy using a combination of raloxifene and alendronate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7579173

Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same

The Board of Regents of the University of Oklahoma · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582442

Methods and compositions for using aleveolar macrophage phospholipase A2

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582648

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582623

Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

The Regents of the University of California · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582641

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582680

Methods and compositions for treating mammalian spinal cord injuries

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582425

Atlastin

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582765

Aryl aniline β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7582289

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)